• Industry – Healthcare
• Issue size – Rs. 871.05 Cr
• Price Band – Rs. 438 – 460 per share
• Lot size – Rs. 14,720 (32 shares for retail investors)
• Book Running lead manager – ICICI Securities Ltd.
• Open for subscription – 10 Dec 2025
• Closing for subscription – 12 Dec 2025

Nephrocare specializes in dialysis treatment they launched their first clinic in 2010 in Hyderabad and scaled to 50 clinics by 2015. The company acquired DaVita India in 2018 with 100 percent stake and has operations running in Uzbekistan, Philippines and Saudi Arabia. Dialysis is treatment given to patients with kidney problem and the company has make good hold in the area,